Dados B3 › MNPR3 × JBSS3
MNPR3 × JBSS3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | MNPR3 | JBSS3 | year |
|---|---|---|---|
| ROE | -218.8% | -0.4% | 2011 |
| ROIC | -12.0%! | 3.4%! | 2011 |
| ROA | 127.6% | 5.0% | 2025 |
| Gross margin | 27.3% | 13.1% | 2025 |
| EBIT margin | 41.9% | 4.9% | 2025 |
| Net margin | 118.3% | 2.6% | 2025 |
| Net debt/EBITDA | -0.64x | 2.49x | 2025 |
| Current ratio | 2.83x | 1.60x | 2025 |
| Revenue growth (1y) | 23.0% | 15.3% | 2025 |
| Revenue growth (5y CAGR) | 10.9% | 12.2% | 2025 |
| Piotroski F-Score | 6/9 | 7/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | MNPR3 | JBSS3 | year |
|---|---|---|---|
| P/E | 0.65x | 9.40x | 2025 × 2024 |
| P/B | 1.74x | 2.02x | 2025 × 2024 |
| EV/EBITDA | 1.06x | 4.90x | 2025 × 2024 |
| FCF yield | 38.1% | 17.1% | 2025 × 2024 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:21 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:21 UTC. If this does not match /saude, you are reading a cached copy.